AGP Wire

AGP

The Business Research Company projects the global medical consumables market will grow from $495.99 billion in 2026 to $757.8 billion by 2030, driven by chronic disease prevalence, home healthcare demand and infection-control spending.

AGP

The medical bionic implant and artificial organs market is projected to rise from $27.31 billion in 2026 to $36.91 billion by 2030, driven by chronic disease growth, aging populations and wider use of smart implants.

AGP

The medical copper tubing market is forecast to grow from $1.88 billion in 2025 to $2.8 billion by 2030 as hospitals expand, surgical volumes rise and healthcare systems invest in safer gas delivery infrastructure.

AGP

The medical deferoxamine mesylate market is projected to grow from $1.28 billion in 2025 to $1.38 billion in 2026, with demand tied to iron overload disorders and chronic transfusion care.

AGP

The global medical device coatings market is projected to grow from $14.05 billion in 2026 to $18.96 billion by 2030, driven by demand for minimally invasive procedures, implant safety and infection control.

AGP

The medical device connectivity market is projected to more than double from $5.71 billion in 2026 to $12.76 billion by 2030, driven by EHR adoption, hospital IT spending and demand for real-time clinical data.

AGP

The medical batteries market is projected to grow from $1.87 billion in 2025 to $2.56 billion by 2030, driven by rising medical device use, wearable tech and stricter safety requirements.

AGP

The global medical and surgical drainage system market is projected to grow from $2.55 billion in 2025 to $3.08 billion by 2030, driven by more surgeries, greater infection-prevention focus and wider use in outpatient care.

AGP

The medical connectors market is projected to grow from $3.04 billion in 2026 to $4.22 billion by 2030 as hospitals, labs and device makers adopt smaller, faster and more specialized connector systems.

AGP

The Business Research Company says the medical coding market will grow from $18.88 billion in 2025 to $20.8 billion in 2026, then reach $30.44 billion by 2030. The report points to EHR adoption, AI-assisted coding and tighter compliance demands as…

AGP

The global medical crutches market is projected to grow from $0.73 billion in 2025 to $1 billion by 2030, driven by injuries, post-surgical rehabilitation, aging populations and rising demand for home healthcare.

AGP

The medical device brazing service market is projected to grow from $2.52 billion in 2025 to $4.12 billion by 2030, driven by rising medical device production, chronic disease cases and demand for leak-proof, biocompatible joins.

AGP

The medical alert systems market is projected to grow from $12.29 billion in 2025 to $20.73 billion by 2030, driven by aging populations, chronic disease, and wider use of remote care tools.

AGP

The medical alert system personal emergency response system market is projected to grow from $12.57 billion in 2026 to $18.03 billion by 2030, fueled by aging populations, wearable devices and remote monitoring demand.

AGP

The Business Research Company says the medical centrifuge market is on track to grow from $2.13 billion in 2025 to about $3.08 billion by 2030, driven by rising chronic disease burden, more diagnostic testing and broader lab automation.

AGP

The Business Research Company says the global medical composites market is set to grow from $1.6 billion in 2025 to $1.84 billion in 2026, driven by higher use in devices, implants and surgical tools.

AGP

The Business Research Company says the global medical device contract manufacturing market is growing quickly as device makers outsource more production to specialized partners.

AGP

The medical device affairs outsourcing market is expanding as manufacturers face tougher regulatory demands and growing compliance workloads.

AGP

MedFire Media has rolled out a 90-minute AI Patient Acquisition Masterclass aimed at helping plastic surgeons attract high-value patients as AI tools increasingly shape provider choice.

AGP

Kuva Labs said it plans to submit a new fully funded offer to Lisata Therapeutics’ board by Aug. 31, 2026. The move revives a previously terminated transaction and could reshape Lisata’s strategic options if the financing is in place.